Co-Diagnostics, Inc. (CODX) Company Cash Volume

Graphic logo of Co-Diagnostics (CODX)

Co-Diagnostics, Inc. (CODX) generates stable revenue based on the sale of PCR systems and the subsequent sale of high-cost reagents. Free cash flow levels confirm this financial stability, where 0.00 determines the latest valuation metric. The company is currently expanding government partnerships to implement diagnostic platforms while simultaneously updating its Co-Primers test line for the agricultural sector and infection control.

Company Cash and Cash Equivalents: Co-Diagnostics Corp (CODX) for 07/04/2022 - 11/21/2026

Analytical breakdowns and data insights for company Co-Diagnostics Corp (CODX)

- stock quotes and analyst forecast:
Summary company analysis:codiagnostics.com
Signature product of Co-Diagnostics Inc

This indicator captures the current level of liquid assets, serving as a fundamental safeguard against market volatility and ensuring operational autonomy. By analyzing the volume of operating cash, investors assess the ability of Co-Diagnostics, Inc. (CODX) to maintain premium pricing for Co-Primers PCR tests, where high diagnostic accuracy allows the company to accumulate significant capital regardless of external macroeconomic shocks.